Clinical and methodological considerations when interpreting meta-analyses of beta-blocker use in patients with chronic obstructive pulmonary disease

Eur Heart J. 2021 Sep 7;42(34):3407-3408. doi: 10.1093/eurheartj/ehab217.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Humans
  • Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

  • Adrenergic beta-Antagonists